(Q73539330)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Serial magnetic resonance imaging in multiple sclerosis: correlation with attacks, disability, and disease stage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E J Orav

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H L Weiner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M J Hohol

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Kikinis

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F A Jolesz

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

164-173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Multiple sclerosis: gadolinium enhancement in MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Multiple sclerosis: serial study of gadolinium-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

White matter changes with normal aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Quantitative follow-up of patients with multiple sclerosis using MRI: reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Multiple sclerosis: A serial study using MRI in relapsing patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Quantitative follow-up of patients with multiple sclerosis using MRI: technical aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Correlation between brain MRI lesion volume and disability in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Adaptive segmentation of MRI data

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900273-8

7 January 2021

10.1016/S0165-5728(99)00273-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713356%20AND%20SRC:MED&resulttype=core&format=json